Follicular lymphoma relapse and refractory treatment

Relapsed and Refractory Follicular Lymphoma - StatPearls - NCBI

For symptomatic late relapsed cases, options include anti-CD20 monoclonal antibodies, chemoimmunotherapy, or novel agents. Treatment choice is ...

Follicular Lymphoma: Relapsed/Refractory - LRF

Chemotherapy, radiation, monoclonal antibodies, and chimeric antigen receptor (CAR) T cell therapy may be used to treat relapsed/refractory FL. Common second- ...

Follicular lymphoma relapse and refractory treatment

These drug combinations have been approved across the UK to treat follicular lymphoma if it relapses (comes back) or doesn't respond to your first treatment ( ...

Treatment of relapsed or refractory follicular lymphoma - UpToDate

Outline · Goals of care and selection of therapy · Lenalidomide plus anti-CD20 antibody for most patients · Single-agent anti-CD20 antibody ...

How I treat early-relapsing follicular lymphoma - ASH Publications

One approach to overcoming therapeutic resistance in this setting is using a more aggressive chemotherapy-based sequence. In patients with ...

When FL Returns or Changes - The Follicular Lymphoma Foundation

Relapse is most likely to happen within the first 2 years after treatment. As time goes on, relapse generally becomes less likely. Although many patients can ...

Prospects in the management of patients with follicular lymphoma ...

In patients with relapsed disease and low tumor burden following initial anti CD20-containing therapy, re-challenge with monoclonal antibodies, ...

Treatment selection for patients with relapsed or refractory follicular ...

Although FL is generally considered an indolent subtype of lymphoma, there is significant clinical and biological heterogeneity in its presentation (2). Most ...

Management of relapsed follicular lymphoma - Rodgers

This section will cover the management of relapsed and refractory disease through a review of clinical scenarios and available therapeutics.

Relapsed and Refractory Follicular Lymphoma - MyLymphomaTeam

Follicular Lymphoma Relapse Symptoms · Other lymph nodes starting to grow quickly · Night sweats · Fever · Weight loss · Enlarged spleen.

About Relapsed or Refractory Follicular Lymphoma - gazyva

What are the symptoms of relapsed or refractory follicular lymphoma? · Enlarged lymph nodes · Fever, fatigue, and night sweats · Unexplained weight loss · Severe or ...

Understanding Follicular Lymphoma: Relapsed/Refractory

Treatment for relapsed/refractory FL is based on a patient's age, overall health, symptoms, prior therapy or therapies, and the duration of remission from ...

Lymphoma that comes back (relapses) or doesn't respond to ...

Doctors might say that your lymphoma is refractory if it comes back within 6 months of treatment. There are treatment options for refractory ...

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical ...

Obinutuzumab or rituximab in combination with CHOP or bendamustine should be used if complete remission and long PFS are the therapeutic goals [ ...

Relapsed/Refractory Follicular Lymphoma Treatment Armamentarium

For patients with relapsed/refractory disease, the most common regimen that currently I use is R2 [lenalidomide and rituximab] in the second ...

Clinical outcomes in patients relapsed/refractory after ≥2 prior lines ...

Patients with follicular lymphoma (FL) can have high response rates to early lines of treatment. However, among FL patients ...

Third Line Treatment of Relapsed Refractory Follicular Lymphoma in ...

In this video, Drs. Andrew M. Evens, L. Elizabeth Budde, and Carla Casulo discuss the third-line treatment of relapsed/refractory follicular lymphoma in a ...

Current Treatment Options for Relapsed/Refractory Follicular ...

How many patients with follicular lymphoma relapse? Most oncologists consider the intention of therapy in follicular lymphoma to be palliative ...

Divergent paths: management of early relapsed follicular lymphoma

We have seen advances in the management of patients with relapsed/refractory FL with the approval of several new treatments including lenalidomide, ...

Relapsed/Refractory Follicular Lymphoma Prognosis and ...

The use of targeted treatments such as rituximab has improved rates of remission. Factor that may influence the prognosis for the patient include age, severity ...